论文部分内容阅读
T_3抑制试验常用甲状腺~(131)Ⅰ摄取率作为判断指标,近年来有人用血清T_4。作者对抗甲状腺药物治疗的67例Graves病患者作了两项指标的观察。67例患者经抗甲状腺药物治疗5～34月后停药进行以血清T_4和甲状腺~(131)Ⅰ摄取率为指标的T_3抑制试验。停药后随访12～25月(平均18月)其中40例于停药后12～18月
T_3 inhibition test commonly used thyroid 131I uptake rate as a judge, in recent years, some people with serum T_4. The author of thyroid drug treatment of 67 patients with Graves disease made two indicators of observation. Sixty-seven patients were treated with antithyroid drugs for 5 to 34 months and then discontinued with T_3 inhibition test using serum T_4 and thyroid uptake of 131I as an index. Follow-up after stopping 12 to 25 months (average 18 months) of which 40 cases after stopping 12 to 18 months